Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism

This ad hoc analysis of a previously conducted phase 3 head-to-head comparison study of evocalcet and cinacalcet in secondary hyperparathyroidism patients undergoing maintenance hemodialysis evaluated the efficacy and safety of combined once-daily oral evocalcet and intravenous vitamin D receptor ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Takashi, Asada, Shinji, Endo, Yuichi, Kawata, Takehisa, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853539/
https://www.ncbi.nlm.nih.gov/pubmed/35176038
http://dx.doi.org/10.1371/journal.pone.0262829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853539/
https://www.ncbi.nlm.nih.gov/pubmed/35176038
http://dx.doi.org/10.1371/journal.pone.0262829

Ejemplares similares